BIAS
AMPE

Beacon Investment Advisory Services’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Beacon Investment Advisory Services’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-568
Closed -$97K – 316
2021
Q4 		$97K Buy
568
+85
+18% +$31.7K ﹤0.01% 304
2021
Q3 		$241K Buy
483
+350
+263% +$162K 0.01% 276
2021
Q2 		$67K Hold
133
– – ﹤0.01% 299
2021
Q1 		$68K Buy
133
+33
+33% +$17K ﹤0.01% 295
2020
Q4 		$48K Hold
100
– – ﹤0.01% 276
2020
Q3 		$29K Buy
+100
New +$24.8K ﹤0.01% 254

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Beacon Investment Advisory Services's AMPE Position: Q1 2022 in Review

Beacon Investment Advisory Services sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022, closing a stake of 568 shares — an estimated $97K sold.

Beacon Investment Advisory Services first reported a position in AMPE in Q3 2020 and held it in 6 quarters. The position peaked at $241K in Q3 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • Beacon Investment Advisory Services reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • Beacon Investment Advisory Services sold 568 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $97K.
  • Beacon Investment Advisory Services first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and held it in 6 quarters.
  • Beacon Investment Advisory Services's Ampio Pharmaceuticals Inc. position peaked at $241K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on Beacon Investment Advisory Services's 13F filing for Q1 2022, filed 12 May 2022.